The development of an effective COVID-19 vaccine is of utmost importance. Most vaccine designs can be classified into three camps: protein based (inactivated vaccines, protein subunit, VLP and T-cell based vaccines), gene based (DNA or RNA vaccines, replicating or non-replicating viral/bacterial...
[4] Beigi RH, Krubiner C, Jamieson DJ, et al. The need for inclusion of pregnant women in COVID-19 vaccine trials. Vaccine 2021; 39: 868–70. [5] Stock SJ, Moore E, Calvert C, et al. Pregnancy outcomes afte...
"This is one of the most prominent trials globally and involves some of the most renowned vaccines companies," Rogers said. "Combined with extensive preclinical research and commercial-scale manufacturing capabilities, COVID-19 S-Trimer is one of the most exciting vaccine programs globally for the ...
BEIJING, June 1 (Xinhua) -- A China-developed intranasal vaccine against COVID-19 has shown to be safe and effective in early-stage human trials, according to a new study published in the journal The Lancet Respiratory Medicine. Compared with currently available COVID-19 vaccines that are adm...
notwithstanding differences in the vector, in the geographical locations of the populations studied, and the neutralization assays used. These COVID-19 vaccine trials are small so inferential caution is warranted, but the explorations are laudable. Ethnic diversity in both these trials was very limited...
BEIJING, April 14 (Xinhua) -- China has approved two COVID-19 inactivated vaccine candidates forclinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday. The two vaccine candidates were developed by Wuhan Institute of Biological Products und...
临床试验分为一期、二期、三期，样本量不断扩大，疫苗的安全性和有效性需经过持续验证、依次“过关”。根据世界卫生组织之前发布的消息，这个时间通常需要一年以上。【重要讲话】疫苗对疫情防控至关重要，对安全性的要求也是第一位的。要加快推进已有的多种技术路线疫苗研发，同时密切跟踪国外研发进展。Vaccine is vital...
This is where human challenge trials come in. They're different from the traditionalphasethree vaccine trials taking place now, where people are given a vaccine orplaceboand asked to go about their everyday lives. Here, researche...
The success of the COVID-19 mRNA vaccines was due in part to the willingness of people to volunteer for vaccine trials. More than 700,000 people are part of the COVID-19 vaccine registry, collected through theCoVPN Volunteer Screening Registry. CoVPN was developed by Oracle in a matter...
BEIJING, Jan. 26 (Xinhua) -- A China-developed mRNA COVID-19 vaccine has been shown to be safe, well-tolerated and effective in early-stage human trials, according to a study published Tuesday in the Lancet Microbe journal. The vaccine ARCoV, which encodes the SARS-CoV-2 spike protein ...